Abstract
The complexes RuCl 3(CTZ) 3·2CH 3OH ( 1) and RuCl 3(KTZ) 2(H 2O)·2H 2O ( 2) were prepared by reaction of RuCl 3·3H 2O with CTZ and KTZ, respectively, while RuCl 2(KTZ) 2 ( 4) was prepared by reaction of RuCl 2(CH 3CN) 4 with KTZ (CTZ=1-[(2-chlorophenyl)diphenylmethyl-1 H-imidazole, and KTZ= cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1 H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine. All the complexes were characterized by NMR spectroscopy and for the paramagnetic species EPR spectroscopy was also employed. The new compounds were tested for in vitro activity against cultures of epimastigotes of Trypanosoma cruzi, the causative agent of Chagas disease, and compared with RuCl 2(CTZ) 2 ( 3) (reported previously) in order to establish some structure–activity correlations. At concentrations of 10 −6 M (DMSO), all the complexes showed higher activity than the parental organic drug against the epimastigote form of the parasite, and Ru(II) complexes seem to be more active than their Ru(III) counterparts for a given nitrogen-donor ligand.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
